The aim of this study is to assess the levothroxine effect on biochemical and clinical symptoms and signs related to hypothyroidism. Patients with subclinical hypothyroidism will be recruited in the study. Exclusion criteria are: clinical hypothyroidism, Pregnancy; thyroid or anti-thyroid medication till 1 month before study; history of coronary artery disease and arrhythmia. Thirty patients with diagnosis of subclinical hypothyroidism will be recruited from Tehran Thyroid Study. Patients will be randomly assigned in two groups (levothyroxine & placebo) for 12 months. In the intervention group , dosage will be titrated to achieve a serum TSH level between 0.3-3.5 mU/L. Main outcome measures are: systolic and diastolic blood pressure, Body Mass Index, clinical hypothyroidism scores based on modified Bilewicks questionnaire, psychomotor tests and serum concentration of thyroid antibodies, lipids, apo-lipoproteines A and B, paraxonase, prolactin, sex hormone binding globulin(SHBG), CPK, calcium, phosphorus, alkaline phosphatase and sodium before and after treatment. At the end of study data will be compared in each groups and between two groups.